Skip To Main Content
Aislyn Oulee on Muck Rack

Aislyn Oulee

As seen in: Medscape, MDedge Dermatology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Aislyn

Contact Aislyn, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Risk for COVID-19 Infection in Patients With Vitiligo

|
By Brandon Smith, Aislyn Oulee, Shahin Shahsavari
| MDedge Dermatology Verified
References Rashighi M, Harris JE. Vitiligo pathogenesis and emerging treatments.Dermatol Clin. 2017;35:257-265. doi:10.1016/j.det.2016.11.014 Wu JJ, Liu J, Thatiparthi A, et al. The risk of COVID-19 in patients with psoriasis—a retrospective cohort study [published online September 20, 2022].. doi:10.1016/j.jaad.2022.07.040 Zhong J, Shen G, Yang H, et al. COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study.. 2020;2:E557-E564.
Open in Who Shared Issue with article?

The doctor is in: Meet California’s next wave of dedicated physicians

|
By Edgar Vega, Aislyn Oulee, Jacqueline A. León, Reyoot Berry
| University of California
After establishing a successful career in public health, including bringing a community wellness center and new services, like palliative care, to a safety net hospital in Porterville, where South Tulare County communities hadn’t had them before, León took the leap of going to medical school so she could inform a larger vision of what Central Valley residents need from the health care system.
Open in Who Shared View Duplicates (2) Issue with article?

Medicare Part D Prescription Claims for Brodalumab: Analysis of Annual Trends for 2017-2019

|
By Grace Ahn, Jashin J. Wu, Aislyn Oulee
| MDedge Dermatology Verified
To the Editor: Brodalumab, a monoclonal antibody targeting IL-17RA, was approved by the US Food and Drug Administration (FDA) in 2017 for the treatment of moderate to severe chronic plaque psoriasis.
Open in Who Shared Issue with article?
See all 5 articles